The HSE Public Health: Health Protection conference was held on 12th October 2023 in The Gresham Hotel, Dublin. The event brought together senior HSE colleagues and expert keynote speakers including Dr Andrea Ammon, Director of the European Centre for Disease Control and Prevention and Professor Breda Smyth, Chief Medical Officer (CMO), Department of Health.
Attendees also heard from Professor Susan Hopkin, Chief Medical Advisor to the UK Health Security Agency (UKHSA) and Dr Greg Martin, HSE HPSC Director, to name but a few, on subjects including antimicrobial resistance, health threats preparedness, vaccination strategy, invasive group A streptococcal infection, migrant health and the influence of deprivation and affluence in relation to COVID19.
The event also provided a forum for networking and learning between colleagues, nationally and internationally.
It's been a brilliant day. It's been our first National Health Protection Conference.
It's a milestone, a landmark as we progress through the health protection strategy.
What was great was seeing so many of our talented colleagues from all over the country
and internationally gathered together here in Dublin today, reflecting on the achievements
of a year in delivering a health protection strategy. We have achieved a huge amount in
the work that we've been seeking to do. We've summarised it in part through the publication
of our first annual report, our year one progress report. This document really doesn't do enough
justice to the work that's been done, but it does demonstrate not only the amount of work
that's been achieved, but the commitment behind it. This work represents the dedication,
the commitment, the professionalism of everyone who's been contributing to getting this job done.
So we have had one of the lowest excess mortality as a result of the pandemic,
but also one of the lowest hospitalisations during peak surges. Also, we had one of the
highest uptake rates in our vaccination programme. And these are all successes because of all of you
here in the room. You're someone who had an alternative career,
the rest of them I'm not sure what they would have ended up doing. You chose to do this over
going to a term with Michael Flatley, ultimately. And isn't it worth it? That's what I was going to
ask you, so why do you do what you do? One of the key essentials of a health professional is
curiosity. And I think that curiosity is a trademark of public health, because it is about
that, the unanswered question, why is this happening? Who's it happening to? What is it
we need to do differently? And is this something we can actually develop? And that often then
becomes a career. It is people working for people. And I think it's a huge privilege,
certainly for me, to be part of that, to be working on behalf of our population. I think,
you know, very few people across society in their various different occupations get the
opportunity to do that. Investments come when politicians are convinced that they save something
by prevention or by investing in measures. So our health economic capacity has to be bolstered
so that we can present data that they can feel confident, if I invest now, I save later. By
getting the evidence to deal with policy, to working with that to get government to provide
the financing and the policy changes and the legislation, and then ensuring that we have the
right data to make sure it's right and update and change it, is life changing for the population,
not just for the single individual in front of you. And so that's why I'm here, for that sort
of population level approach. For us, for this job, for this time, it has never been more important
for us to work collaboratively, and the internationalist agenda is even more
important now that so many parts of the world are even more polarised, as Greg said in his
presentation, than they had been previously. Because like the theme goes, nobody's safe
until everybody's safe. So even if Ireland is safe, if other countries are not safe,
disease can cross the border very easily. So it was very good. I think it's really important that
we understand the threats across the world. So we need to collaborate to do that. It's really
important that we understand the threats in our borders, we need to collaborate to do that.
We learn so much from each other and how we respond. And using all of that makes us better
in protecting the health of the public. I think that, I think one of, well, I've enjoyed many
things. One of the things I liked was Dr. Andrew Ann talking about health economics.
I think that's a really important part of the work we do, to show the benefit of the work we do.
It's been absolutely lovely listening to my colleagues talk about what we've done with
respect to the strategy so far. I've really enjoyed learning about the stuff in immunisation
and vaccine space, the health preparedness and the threats preparedness. It's been amazing to
listen to. So overall, fantastic morning so far. And I think that for me, the key messages are that
as we move in health protection towards an all-hazards, one health-based approach,
that really the key things are collaboration, both regionally, nationally, internationally,
multidisciplinary working and also community engagement. And I think really underpinning
that is strong public health leadership and advocacy, working to reduce health inequalities
and really advocating for those marginalised populations that we serve.
So just thinking about the focus of nobody's safe until everybody's safe. I think vaccines
is a really good example of that. And you can see here some work that was done for European
Immunisation Week a few years ago, showing in terms of our cases of some of our vaccine
preventable diseases in Ireland in 1950. And then now in, that was in 2017. And those circles
would be even smaller now, showing how much effect we have had in the vaccine programmes
in terms of reducing the morbidity and mortality of infectious diseases. And in terms of the work
that we do, we don't know that we protected you or you against getting an infectious disease,
but we do know there are more people alive and more people who haven't been affected by
infectious diseases because of our high quality programmes.
Running through the health security framework here that we're dealing with, we have all
hazards approach, interoperability, intersectoral networks are key. And we've mentioned the
avian influenza work with our colleagues in the animal health side. We also have to monitor and
evaluate everything we do. I mean, preparedness is not an intangible. We have to be able to
detect it and to measure it and to monitor it so that we can improve at what you measure you value.
And finally, we have a continuous quality improvement approach.
So, it prompted a clinical review of paediatric cases, but what differentiates more severely
ill eye gas cases from less severely ill eye gas paediatric cases? Ireland has undertaken
a study and ECDC, we're extremely grateful to the European EU Health Task Force, have also
assisted us and expanded it to Europe. An IMT was formed in December, which
undertook the investigation of this. IMT chaired by Dr. Ena Fallon. And this multidisciplinary
IMT monitored and provided support for the investigation and management of this outbreak.
All the presentations gave a good overview of what Ireland is doing. And I am very grateful
for the good partnership with Ireland. The ambition for our programme is nothing
but upwards. We have an ambition to make Ireland a international centre of excellence
in health protection and public health. Our ambition is not unrealistic, it is grounded
in our own confidence and our ability to do this, and the strength of the partnerships
that we have and the ones that we're going to build.